OFIX

Orthofix Medical Inc.

Nasdaq · Surgical & Medical Instruments & Apparatus · CIK 0000884624
$9.31 +0.87% $376.3M
Insider Buying Cluster (3 insiders)High Impact Filing (7/10)7 New Institutional Positions
Vol
Market Cap$376.3M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (73%)
Inst. Holders50 funds
Inst. Value$172.7M
Inst. Activity7 buys / 2 sells
Insider Activity8B / 17S
Insider Net $$650.9K
SEC Reports7
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·CIK 0000884624·Prev Close $9.23

Recent Activity

Jun 10, 2026 Insider
Paolucci Michael E was granted 14,965 shares
Director
Jun 10, 2026 Insider
Maniar Shweta was granted 14,965 shares
Director
Jun 10, 2026 Insider
BURRIS WAYNE was granted 14,965 shares
Director
May 21, 2026 SEC
Orthofix disclosed that CMS updated billing requirements for non-invasive bone growth stimulators, effective May 18, 202
8-K — Impact 7/10
May 21, 2026 short_volume
Short Volume: OFIX — 57.6% short (0.3M / 0.6M)
Short: 342,000 | Exempt: 22,825 | TRF Vol: 593,838 | Short Ratio: 57.6% | Off-exchange volume (dark
May 5, 2026 SEC
Orthofix reported Q1 2026 pro forma net sales of $196.4M (+2.7% YoY constant currency) and a GAAP net loss of $(20.9)M,
8-K — Impact 4/10
Apr 29, 2026 SEC
Orthofix Medical Inc. filed additional definitive proxy materials (DEFA14A) reminding shareholders of the June 10, 2026
DEFA14A — Impact 2/10
Inst.
TUDOR INVESTMENT CORP ET — ADD
262,974 shares ($3.0M)

Price Targets

$15.00 +61.1% upside Strong Buy
Current $9.31 Low $12.00 Median $15.00 High $18.00 4 analysts
$12.00 $18.00

Analyst Ratings

Buy73% buy · 11 analysts
4Strong Buy
4Buy
3Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 22, 2026 Canaccord Genuity MAINTAIN Buy → Buy
May 22, 2026 Barrington Research MAINTAIN Outperform → Outperform
May 22, 2026 Stifel MAINTAIN Buy → Buy
Apr 10, 2026 Barrington Research MAINTAIN Outperform → Outperform
Mar 9, 2026 Stifel MAINTAIN Buy → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.03 $-0.03 — $-0.03 -123% YoY 1
Next Q $0.05 $0.05 — $0.05 -75% YoY 1
Current FY $0.19 $0.19 — $0.19 -61% YoY 1
Next FY $0.71 $0.03 — $1.39 274% YoY 2

Latest Reports

BEARISH 8-K 7/10
Orthofix disclosed that CMS updated billing requirements for non-invasive bone growth stimulators, effective May 18, 202
May 21, 2026
NEUTRAL 8-K 4/10
Orthofix reported Q1 2026 pro forma net sales of $196.4M (+2.7% YoY constant currency) and a GAAP net loss of $(20.9)M,
May 5, 2026

Top Institutional Holders

FundValueMove
Rubric Capital Management LP$42.7M—
BlackRock, Inc.$36.8M—
VANGUARD CAPITAL MANAGEMENT LLC$19.0M—
STATE STREET CORP$10.4M—
DIMENSIONAL FUND ADVISORS LP$9.7MADD

Recent Insider Trades

DateInsiderTypeValue
Jun 10, 2026Paolucci MichaelA$0.00
Jun 10, 2026Maniar ShwetaA$0.00
Jun 10, 2026BURRIS WAYNEA$0.00
Jun 10, 2026HENNEMAN JOHNA$0.00
Jun 10, 2026CAPPS VICKIEA$0.00
50 institutional holders with $172.7M total value (15,042,195 shares) as of 2026-Q1. Top holders: Rubric, BlackRock,, VANGUARD. Net buying activity: 7 institutions added/increased vs 2 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1Rubric Capital Management LP3,721,715$42.7M24.7%—
2BlackRock, Inc.3,207,789$36.8M21.3%—
3VANGUARD CAPITAL MANAGEMENT LLC1,655,449$19.0M11.0%—
4STATE STREET CORP907,432$10.4M6.0%—
5DIMENSIONAL FUND ADVISORS LP841,521$9.7M5.6%ADD +32.2%
6VANGUARD PORTFOLIO MANAGEMENT LLC396,568$4.5M2.6%—
7CHARLES SCHWAB INVESTMENT MANAGEMENT INC325,743$3.7M2.2%—
8GOLDMAN SACHS GROUP INC324,425$3.7M2.2%—
9TUDOR INVESTMENT CORP ET AL262,974$3.0M1.7%ADD +29.8%
10VANGUARD FIDUCIARY TRUST CO256,022$2.9M1.7%—
11GABELLI FUNDS LLC223,943$2.6M1.5%ADD +70.8%
12BANK OF AMERICA CORP /DE/212,169$2.4M1.4%TRIM -56.9%
13Russell Investments Group, Ltd.211,734$2.4M1.4%—
14GAMCO INVESTORS, INC. ET AL201,800$2.3M1.3%—
15ARROWSTREET CAPITAL, LIMITED PARTNERSHIP200,230$2.3M1.3%DOUBLED +1670.1%
16MORGAN STANLEY197,346$2.3M1.3%ADD +30.3%
17Nuveen, LLC173,734$2.0M1.2%TRIM -47.7%
18Point72 Asset Management, L.P.158,880$1.8M1.1%ADD +80.1%
19GREAT LAKES ADVISORS, LLC153,866$1.8M1.0%—
20Trexquant Investment LP127,216$1.5M0.8%DOUBLED +216.8%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
TUDOR INVESTMENT CORP ET ALADD202,606262,974+29.8%$3.0M2026-Q1
Nuveen, LLCTRIM332,042173,734-47.7%$2.0M2026-Q1
Point72 Asset Management, L.P.ADD88,216158,880+80.1%$1.8M2026-Q1
RENAISSANCE TECHNOLOGIES LLCADD81,391101,991+25.3%$1.2M2026-Q1
Assenagon Asset Management S.A.DOUBLED21,31071,286+234.5%$817.6K2026-Q1
BALYASNY ASSET MANAGEMENT L.P.ADD15,72528,055+78.4%$321.8K2026-Q1
STRS OHIODOUBLED9,20020,400+121.7%$234.0K2026-Q1
CWM, LLCADD4,5385,750+26.7%$66.0K2026-Q1
NISA INVESTMENT ADVISORS, LLCNEAR_EXIT66674-88.9%$849.002026-Q1
Nuveen, LLCTRIM535,272332,042-38.0%$5.0M2025-Q4
MORGAN STANLEYADD172,405224,643+30.3%$3.4M2025-Q4
Trexquant Investment LPDOUBLED43,083136,469+216.8%$2.1M2025-Q4
PANAGORA ASSET MANAGEMENT INCADD48,10961,192+27.2%$927.7K2025-Q4
WELLS FARGO & COMPANY/MNADD29,96943,724+45.9%$662.9K2025-Q4
Assenagon Asset Management S.A.TRIM29,42921,310-27.6%$323.1K2025-Q4
PRUDENTIAL FINANCIAL INCTRIM16,90211,001-34.9%$166.8K2025-Q4
D. E. Shaw & Co., Inc.TRIM17,48210,550-39.7%$159.9K2025-Q4
Allworth Financial LPDOUBLED21235+1019.0%$3.6K2025-Q4
PRICE T ROWE ASSOCIATES INC /MD/ADD46,68963,245+35.5%$959.002025-Q4
CWM, LLCDOUBLED1,9204,538+136.4%$69.002025-Q4
Nuveen, LLCDOUBLED77,232535,272+593.1%$7.8M2025-Q3
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED17,550310,645+1670.1%$4.5M2025-Q3
BANK OF AMERICA CORP /DE/TRIM687,410296,254-56.9%$4.3M2025-Q3
TUDOR INVESTMENT CORP ET ALDOUBLED58,847217,044+268.8%$3.2M2025-Q3
MORGAN STANLEYTRIM250,184172,405-31.1%$2.5M2025-Q3
18 unique insiders with 42 transactions. Net insider value: $650.9K ($3.7M bought, $3.0M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 10, 2026Paolucci Michael EDirectorAWARD14,965——
Jun 10, 2026Maniar ShwetaDirectorAWARD14,965——
Jun 10, 2026BURRIS WAYNEDirectorAWARD14,965——
Jun 10, 2026HENNEMAN JOHN B IIIDirectorAWARD14,965——
Jun 10, 2026CAPPS VICKIE LDirectorAWARD14,965——
Jun 10, 2026Finegan MichaelDirectorAWARD20,721——
Jun 10, 2026Hannon JasonDirectorAWARD14,965——
Jun 10, 2026Kummeth Charles R.DirectorAWARD14,965——
Jun 10, 2026Bazaar Alan LeeDirectorAWARD14,965——
May 22, 2026Juniper Investment Company, LLC10%+ OwnerSELL242,000$10.70$2.6M
May 7, 2026Engine Capital Management, LP10%+ OwnerBUY18,192$12.20$221.9K
May 7, 2026HENNEMAN JOHN B IIIDirectorBUY5,000$12.26$61.3K
May 6, 2026Engine Capital Management, LP10%+ OwnerBUY38,154$12.23$466.5K
May 5, 2026Engine Capital Management, LP10%+ OwnerBUY110,039$11.99$1.3M
Apr 16, 2026Cedron Jorge AndresCLOSELL3,743$12.82$48.0K
Mar 17, 2026Vitale LucasCP&BOOSELL4,269$11.92$50.9K
Mar 10, 2026CAPPS VICKIE LDirectorBUY100$12.44$1.2K
Mar 9, 2026CAPPS VICKIE LDirectorBUY2,500$12.48$31.2K
Mar 5, 2026Andrews JulieCFOSELL2,363$12.55$29.7K
Mar 5, 2026Vitale LucasCP&BOOSELL1,141$12.55$14.3K
Mar 5, 2026McPherron AvivaPres, Global Ops & QualSELL1,263$12.55$15.9K
Mar 5, 2026Cedron Jorge AndresCLOSELL1,370$12.55$17.2K
Mar 5, 2026Calafiore MassimoPresident & CEOSELL6,031$12.55$75.7K
Mar 5, 2026Fisher PatrickPresident, Global Limb ReconSELL758$12.55$9.5K
Mar 5, 2026REINHARDT MAXPresident, Global SpineSELL1,053$12.55$13.2K
Mar 4, 2026Andrews JulieCFOSELL2,425$12.92$31.3K
Mar 4, 2026Calafiore MassimoPresident & CEOSELL6,189$12.92$79.9K
Mar 4, 2026McPherron AvivaPres, Global Ops & QualSELL1,296$12.92$16.7K
Mar 4, 2026Cedron Jorge AndresCLOSELL1,405$12.92$18.1K
Mar 4, 2026Vitale LucasCP&BOOSELL1,171$12.92$15.1K
Mar 4, 2026Fisher PatrickPresident, Global Limb ReconSELL778$12.92$10.0K
Mar 4, 2026REINHARDT MAXPresident, Global SpineSELL1,080$12.92$13.9K
Mar 3, 2026Calafiore MassimoPresident & CEOAWARD115,119——
Mar 3, 2026Calafiore MassimoPresident & CEOAWARD273,279——
Mar 3, 2026McPherron AvivaPres, Global Ops & QualAWARD23,024——
Mar 3, 2026Vitale LucasCP&BOOAWARD45,546——
Mar 3, 2026Fisher PatrickPresident, Global Limb ReconAWARD21,105——
Mar 3, 2026McPherron AvivaPres, Global Ops & QualAWARD54,656——
Mar 3, 2026Vitale LucasCP&BOOAWARD19,186——
Mar 3, 2026Fisher PatrickPresident, Global Limb ReconAWARD50,101——
Feb 25, 2026Engine Capital Management, LP10%+ OwnerBUY9,959$12.96$129.1K
Feb 24, 2026Engine Capital Management, LP10%+ OwnerBUY117,076$12.55$1.5M
7 SEC filing reports analyzed. Sentiment: 1 bullish, 2 bearish, 0 mixed, 4 neutral. Avg impact: 4.6/10.
BEARISH 8-K 7/10
Orthofix disclosed that CMS updated billing requirements for non-invasive bone growth stimulators, e
May 21, 2026
NEUTRAL 8-K 4/10
Orthofix reported Q1 2026 pro forma net sales of $196.4M (+2.7% YoY constant currency) and a GAAP ne
May 5, 2026
NEUTRAL DEFA14A 2/10
Orthofix Medical Inc. filed additional definitive proxy materials (DEFA14A) reminding shareholders o
Apr 29, 2026
BULLISH 8-K 7/10
Orthofix reported preliminary Q1 2026 net sales of $196.7 million (up 1.6% YoY) and reaffirmed its f
Apr 21, 2026
NEUTRAL CLUSTER 3/10
Lucas Vitale, Chief Planning and Business Operations Officer at Orthofix Medical, sold 4,269 shares
Mar 19, 2026
BEARISH CLUSTER 6/10
Over the past seven days, multiple executives at Orthofix Medical Inc. (OFIX) sold shares in the ope
Mar 10, 2026
NEUTRAL CLUSTER 3/10
A cluster of insider transactions at Orthofix Medical Inc. (OFIX) shows two executives, the CLO and
Mar 6, 2026
∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Buy (73% buy). Based on 11 analysts: 4 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$15.00 mean target +61.1% upside Strong Buy (3.00)
$12.00 Low $18.00 High
MetricValue
Current Price$9.31
Target Low$12.00
Target Mean$15.00
Target Median$15.00
Target High$18.00
# Analysts4
RecommendationStrong Buy (3.00)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
 $-0.03 $-0.03 $-0.03 -123.2% — 0↑ 1↓ $0.2B 3.0% 1
Next Q
2026-09-30
 $0.05 $0.05 $0.05 -74.7% — 0↑ 1↓ $0.2B 2.8% 1
Current FY
2026-12-31
 $0.19 $0.19 $0.19 -61.0% — 1↑ 0↓ $0.8B 2.6% 1
Next FY
2027-12-31
 $0.71 $0.03 $1.39 273.7% — 0↑ 1↓ $0.9B 5.2% 2

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.030
7d ago$0.000-0.030
30d ago$0.000-0.030
60d ago$0.000-0.030
90d ago$0.115-0.145
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 22, 2026 Canaccord Genuity MAINTAIN Buy Buy
May 22, 2026 Barrington Research MAINTAIN Outperform Outperform
May 22, 2026 Stifel MAINTAIN Buy Buy
Apr 10, 2026 Barrington Research MAINTAIN Outperform Outperform
Mar 9, 2026 Stifel MAINTAIN Buy Buy
Feb 26, 2026 Canaccord Genuity MAINTAIN Buy Buy
Feb 25, 2026 Barrington Research MAINTAIN Outperform Outperform
Feb 17, 2026 Barrington Research MAINTAIN Outperform Outperform
Jan 27, 2026 TD Cowen INITIATE — Hold

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20264430073%
May 1, 20264430073%
Apr 1, 20264430073%
Mar 1, 20264430073%
Feb 1, 20265430075%
Jan 1, 20265420082%
Strong BuyBuyHoldSellStrong Sell
∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 21, 2026
short_volume
Short Volume: OFIX — 57.6% short (0.3M / 0.6M)
Short: 342,000 | Exempt: 22,825 | TRF Vol: 593,838 | Short Ratio: 57.6% | Off-exchange volume (dark pool + OTC)
May 5, 2026
earnings_calendar
OFIX Q1 2026 Earnings Scheduled — 2026-05-05
Feb 24, 2026
earnings_calendar
OFIX Q4 2025 Earnings Before Market Open — 2026-02-24